Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Research programme: influenza virus vaccines - Vivaldi Biosciences

Drug Profile

Research programme: influenza virus vaccines - Vivaldi Biosciences

Alternative Names: A/H7N9 LAIV - Vivaldi Biosciences; delta-NS1 LAIV for paediatrics - Vivaldi Biosciences; Influenza A/H7N9 vaccine - Vivaldi Biosciences; Int-NS1 LAIV - Vivaldi Biosciences; VB-126

Latest Information Update: 28 Feb 2018

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Vivaldi Biosciences
  • Developer National Institute of Allergy and Infectious Diseases; Vivaldi Biosciences
  • Class Influenza virus vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • No development reported Influenza A virus H7N9 subtype; Influenza virus infections

Most Recent Events

  • 28 Feb 2018 No recent reports of development identified for preclinical development in Influenza-A virus H7N9 subtype(Prevention) in USA (Intranasal)
  • 04 Nov 2017 No recent reports of development identified for preclinical development in Influenza-virus-infections(In the elderly, Prevention) in USA (Intranasal)
  • 21 Jan 2014 Preclinical development is ongoing for seasonal Influenza virus infections (prevention, in the elderly) in USA
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top